Filing Details
- Accession Number:
- 0001012975-14-000138
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-05 17:18:33
- Reporting Period:
- 2014-03-03
- Filing Date:
- 2014-03-05
- Accepted Time:
- 2014-03-05 17:18:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1177648 | Enanta Pharmaceuticals Inc | ENTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106929 | Tvm Iv Gmbh & Co Kg | C/O Tvm Capital Group Ottostrasse 4 Munich 2M 80333 | No | No | Yes | No | |
| 1133921 | Helmut Schuhsler | C/O Tvm Capital Group Ottostrasse 4 Munich 2M 80333 | No | No | Yes | No | |
| 1133935 | Tvm Medical Ventures Gmbh & Co Kg | C/O Tvm Capital Group Ottostrasse 4 Munich 2M 80333 | No | No | Yes | No | |
| 1183073 | Tvm V Life Science Ventures Gmbh & Co Kg | C/O Tvm Capital Croup Ottostrasse 4 Munich 2M 80333 | No | No | Yes | No | |
| 1342938 | Tvm V Life Science Ventures Management Gmbh & Co. Kg | C/O Tvm Capital Group Ottostrasse 4 Munich 2M 80333 | No | No | Yes | No | |
| 1342939 | Gmbh Capital Tvm | C/O Tvm Capital Group Ottostrasse 4 Munich 2M 80333 | No | No | Yes | No | |
| 1342940 | Tvm Iv Management Gmbh & Co. Kg | C/O Tvm Capital Group Ottostrasse 4 Munich 2M 80333 | No | No | Yes | No | |
| 1397372 | Alexandra Goll | C/O Tvm Capital Group Ottostrasse 4 Munich 2M 80333 | No | No | Yes | No | |
| 1398596 | Stefan Fischer | C/O Tvm Capital Group Ottostrasse 4 Munich 2M 80333 | No | No | Yes | No | |
| 1398598 | Hubert Birner | C/O Tvm Capital Group Ottostrasse 4 Munich 2M 80333 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-03-03 | 1,402 | $38.83 | 351,635 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-03 | 1,874 | $38.83 | 469,929 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-03 | 5,795 | $38.83 | 1,453,414 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-04 | 66,506 | $38.82 | 285,129 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-04 | 88,877 | $38.82 | 381,052 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-04 | 274,880 | $38.82 | 1,178,534 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.03, inclusive. Each Reporting Person undertakes to provide to Enanta Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The shares are directly held by TVM Medical Ventures GmbH & Co. KG ("Medical Ventures"), the general partner of which is TVM Capital GmbH ("TVM Capital"), for which Alexandra Goll ("Goll") and Helmut Schuhsler ("Schuhsler"), each members of the investment committee of TVM Capital, share voting and investment authority over the shares held by Medical Ventures with the other members of the investment committee. Each of TVM Capital, Goll and Schuhsler disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
- The shares are directly held by TVM IV GmbH & Co. KG ("TVM IV"), the managing limited partner of which is TVM IV Management GmbH & Co. KG ("TVM IV Management"), for which Goll and Schuhsler, each members of the investment committee of TVM IV Management, share voting and investment authority over the shares held by TVM IV with the other members of the investment committee. Each of TVM IV Management, Goll and Schuhsler disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
- The shares are directly held by TVM V Life Science Ventures GmbH & Co. KG ("TVM V"), the managing limited partner of which is TVM V Life Science Ventures Management GmbH & Co. KG ("TVM V Management"), for which Hubert Birner ("Birner"), Stefan Fischer ("Fischer"), Goll and Schuhsler, each members of the investment committee of TVM V Management, share voting and investment authority over the shares held by TVM V. Each of TVM V Management, Birner, Fischer, Goll and Schuhsler disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.62, inclusive. Each Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
